Topol: Clinical trials offer exciting examples of convergence of digital health and drug development
One of the exciting and frustrating things about convergence, particularly in healthcare, is that it’s tough to predict how the hybrid technologies will find their way to market. The process of ...
We perform convergence tests on the U.S. states for per capita income from 1930 to 2009. Cross-sectional tests support overall σ-convergence and β-convergence but may not hold true for the last three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results